Safety, pharmacokinetics, and pharmacodynamics of sofnobrutinib, a novel non-covalent BTK inhibitor, in healthy subjects: First-in-human phase I study.

sofnobrutinib (AS-0871) - Carna Biosci

http://www.ncbi.nlm.nih.gov/pubmed/39523516

Akinori Arimura; Christine Voors-Pette; Jart A F Oosterhaven; Katsuhiro Mihara; Kyoko Miyamoto; Marian Geldof; Marieke van den Dobbelsteen; Masaaki Sawa; Naomi Matsuda; Robert M Miller; Shirou Kirita; Yuji Sato

Nov 16, 2024